Feldene
New Arthritis Drug Xeljanz Gets FDA Approval »
"Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis.
Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a "...
Read the New Arthritis Drug Xeljanz Gets FDA Approval article »
Feldene
INDICATIONS
Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
FELDENE (piroxicam) is indicated:
- For relief of the signs and symptoms of osteoarthritis.
- For relief of the signs and symptoms of rheumatoid arthritis.
DOSAGE AND ADMINISTRATION
Carefully consider the potential benefits and risks of FELDENE (piroxicam) and other treatment options before deciding to use FELDENE (piroxicam) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
After observing the response to initial therapy with FELDENE (piroxicam) , the dose and frequency should be adjusted to suit an individual patient's needs.
For the relief of rheumatoid arthritis and osteoarthritis, the recommended dose is 20 mg given orally once per day. If desired, the daily dose may be divided. Because of the long half-life of FELDENE (piroxicam) , steady-state blood levels are not reached for 7-12 days. Therefore, although the therapeutic effects of FELDENE (piroxicam) are evident early in treatment, there is a progressive increase in response over several weeks and the effect of therapy should not be assessed for two weeks.
HOW SUPPLIED
FELDENE® (piroxicam) Capsules for oral administration:
Bottles of 100: 10 mg (NDC 0069-3220-66) maroon and blue #322
Bottles of 100: 20 mg (NDC 0069-3230-66) maroon #323
Distributed by: Pfizer Labs Division of Pfizer Inc, NY, NY 10017. Revised July 2010
Last reviewed on RxList: 9/14/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Feldene Information
Feldene - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Arthritis
Get the latest treatment options






